Last reviewed · How we verify
AT193
At a glance
| Generic name | AT193 |
|---|---|
| Sponsor | Azora Therapeutics Australia Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa (PHASE1)
- Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |